These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22452128)

  • 1. [Renin angiotensin system inhibitors: too much of a good thing can be dangerous].
    Burnier M; Martin PY
    Rev Med Suisse; 2012 Feb; 8(330):443-4. PubMed ID: 22452128
    [No Abstract]   [Full Text] [Related]  

  • 2. [Debate concerning the optimal blockage of the renin-angiotensin system].
    Choukroun G
    Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Lyle PA; Tershakovec AM; Devereux RB; Oparil S; Dahlöf B; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Wedel H
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):729-45. PubMed ID: 16262560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neutropenia induced by low doses of captopril in hypertensive patients without associated autoimmune disease].
    Ortega G; Molina M; Rivera MD; Serrano C
    An Med Interna; 1999 Aug; 16(8):436. PubMed ID: 10507176
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment for the elderly hypertensive patient with renal insufficiency].
    Kobayashi K; Kanno Y; Suzuki H
    Nihon Rinsho; 2005 Jun; 63(6):1047-51. PubMed ID: 15948389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiorenal disease development under chronic renin-angiotensin-aldosterone system suppression.
    Sarafidis PA; Ruilope LM
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):217-9. PubMed ID: 22389391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.
    Mourad JJ; Le Jeune S; Pirollo A; Mourad C; Gaudouen Y; Lopez-Sublet M
    Curr Med Res Opin; 2010 Sep; 26(9):2263-76. PubMed ID: 20690889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
    Probstfield J
    J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm.
    Schmieder RE
    Clin Exp Hypertens; 2010 Jan; 32(1):35-42. PubMed ID: 20144071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAPPP trial. Captopril Prevention Project.
    Lim PO
    Lancet; 1999 May; 353(9166):1793; author reply 1795-6. PubMed ID: 10348009
    [No Abstract]   [Full Text] [Related]  

  • 16. [ACE inhibitors in the treatment of hypertension in elderly patients].
    Evéquoz D; Reichenstein T; Waeber B; Nussberger J; Brunner HR
    Schweiz Rundsch Med Prax; 1991 Jun; 80(25):701-6. PubMed ID: 1857901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing and reversing target organ damage by treatment of the renin-angiotensin system.
    Krakoff LR; Rajasekharaiah V
    Mt Sinai J Med; 1998 Mar; 65(2):125-32. PubMed ID: 9520516
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of calcium channel blocker in hypertensive patients with chronic kidney disease].
    Morihira M; Kikuchi K; Nakagawa N; Fujino T; Hasebe N
    Nihon Jinzo Gakkai Shi; 2009; 51(4):451-5. PubMed ID: 19601552
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combination drug therapy in hypertension].
    Tsukiyama H; Shigemasa T; Ikoma E
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():596-602. PubMed ID: 15171443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.